Publication
Investment and M&A trends in FinTech
2023 was a challenging year for global FinTech M&A and investment. Intense macroeconomic and geopolitical headwinds led to investor caution.
Publication | October 2015
Canada’s Patented Medicines Notice of Compliance Regulations (PM(NOC) Regulations) are loosely based on the U.S. Hatch-Waxman regime and are meant to link patent protection with the drug approval process. As required by the PM(NOC) Regulations, Health Canada maintains a Patent Register (similar to the U.S. Orange Book).
Read more (pdf 1,006kb)
Publication
2023 was a challenging year for global FinTech M&A and investment. Intense macroeconomic and geopolitical headwinds led to investor caution.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023